The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA)

G Dooijewaard, P A van Boheemen, D J Binnema, C Kluft

    Research output: Contribution to journalArticleAcademicpeer-review

    Original languageEnglish
    Pages (from-to)278-280
    JournalAnnals of the New York Academy of Sciences
    Volume667
    Issue number1
    DOIs
    Publication statusPublished - 4 Dec 1992

    Keywords

    • cardiovascular diseases
    • fibrinolysis
    • thrombosis

    Cite this